Canadian Agency for Drugs and Technologies in Health
Introduction
The purpose of this paper is to introduce a health-related organization that we are not familiar with and investigate the organization. For this paper, the organization that will be investigated will be the Canadian Agency of Drugs and Technologies in Health (CADTH). The following sections will discuss what the organization is about, its mission and mandate, how the organization is structured, funding, and why does the organization exists.
What is the organization?
The Canadian Agency of Drugs and Technologies in Health (CADTH) is an independent, not-for-profit organization that is based in Ottawa but has liaison officers across Canada. The organization is responsible in providing Canada’s health care decision-makers with objective evidence to help make informed decisions about the optimal use of drugs and medical devices in our healthcare system. They are considered to be an organization that is a trusted pan-Canadian source of credible health care evidence.
The organization’s purpose outlines that it harmonizes the scientific approach of its products and services, increased production of its HTAs and rapid reviews, invited patient engagement, and welcomed the pan-Canadian Oncology Drug Review to the organization. Their work is one of their world’s leading health technology assessment (HTA) organizations and essential contributor to evidence-informed decision-making in Canada.
CADTH’s organizational chart
Health care expenditure accounted for an estimated 11% (214.9 billion) of Canada’s GDP in 2014 (CIHI, 2014). Canada boasts a universal, cost-effective and fair health care system to its citizens (Picard, 2010). However, despite great claims and large expenses incurred Canada’s health care system has been reported inefficient in it’s delivery to the population (Davis, Schoen, & Stremikis, 2010; Picard, 2010). As inconsistencies exist in health care delivery across the country, choosing priorities for the health of the Canadian people becomes of vital importance. In Ontario, progress toward a better health care system has been stated to be moving forward by putting the needs of the “patient’s first” (Ministry of Health and Long-Term Care [MOHLTC], 2015). This policy brief will give a background of health care issues in Canada related to Ontario. Three evidence-based priorities will be suggested for Ontario’s health policy agenda for the next three to five years. Furthermore, through a critical analysis of these issues a recommendation of the top priority issue for the agenda will be presented.
Since 1984, Canada has established a publicly funded healthcare system through the provisions of the “Canada Health Act,” which states that the objective of Canadian health care policy is to “facilitate reasonable access to health services without financial or other barriers” (“Canada Health Act” 1). However, many Canadians feel Canada’s healthcare system is financially restricting. This system does not cover many prescription drugs or speciality drugs, which are needed for 41% of Canadian citizens aged 6-79 years old (Rotterman, Michelle et al. 1). This excludes elderly citizens who require even more medications. According to the Canadian Institute for Health Information it is estimated the provincial and territorial governments spent $10.4 billion on prescription medications in 2014 (Matteo, Livio Di 2).
Although Canada has always been considered a small country, its achievements in medicine are far from small. They have greatly benefited Canada and improved the country’s way of life. In fact, Canadian physician Dr. Frederick Banting discovered insulin to treat diabetes. Also, Michael smith developed site-directed mutagenesis to alter and identify genes. Lastly, doctors at Toronto Hospital For Sick Children produced Pablum to treat rickets. These notable breakthroughs in Canadian medicine have positively impacted Canadian life.
As a result of the CRG’s impetus, several dominant trends have emerged. First, Canada has witnessed collaboration and synergy across organizations. Second, Canada has curated new knowledge regarding the economic impact of health care inequalities and the type of collaborative needed to reduce them. Ultimately, the CRG has been a tremendous tool for acquiring and sharing knowledge; however, the problem still remains. Great disparity in quality of health still exists in the populations identified by the
“For over 60 years, Centers for Disease Control and Prevention (CDC) has been dedicated to protecting health and promoting quality of life through the prevention and control of disease, injury, and disability,” (CDC, 2012, p. 1). The organization has a focus of decreasing the health and economic disadvantages of the principal reasons of demise and incapacity through diverse programs, thus safeguarding an extended, prolific, vigorous life for people, (CDC, 2012). This paper will expound on The Centers for Disease Control and Prevention and it is enhancement to the fundamental operations
The health care system in Ontario has been subjected to a lot of criticism and investigation since its introduction midway through the twentieth century. In the past decade, there has been a significant increase in the demand of healthcare, due to increase in the population from immigration and also, an increase in the chronic diseases among the residents of Ontario, which in turn has affected the overall quality of the provision of healthcare. Due to its availability to wide range of people it has become evident that the health care system has been restricted by incorporation of various strict time-consuming policies, which may cause the current healthcare system to be unsustainable in the future. Therefore, healthcare industry has added resources to accommodate increase in demands and the needs of the Ontarians, but this does not eliminate the problem that Ontario lacks a system-wide and sustained approach to improve quality of primary healthcare, which will be further discussed in the paper.
The purpose of this paper is to introduce a health-related organization that we were not familiar with and to investigate the organization. For this paper, the organization that will be investigated will be the Canadian Agency of Drugs and Technologies in Health (CADTH). The following sections will discuss what the organization is about, its mission and mandate, how the organization is structured, how are they funded, and why does the organization exist and do the work that they accomplish.
A strategy for accessing new treatments at an affordable price for all Canadians is through a bulk purchasing alliance (12). Bulk purchasing involves provincial governments collectively purchasing medicines in larger volumes for the purpose of price reductions from manufacturers (11). Provincial governments are collectively the largest purchasers of drugs in Canada, hence the concern for price increases of drugs (5). Federal leadership is required to coordinate a national approach to bulk purchasing. The newly elected Government of Canada promised to work with provincial and territorial governments to buy patent and generic drugs in bulk through the
Morgan, S.G., Daw, J.R., & Law, M.R. (2013, August). The institute’s commitment to quality: Rethinking pharmacare in Canada. Health policy, 384, 3-15. Retrieved from https://www.cdhowe.org/pdf/Commentary_384.pdf
The SCHC addressed meaningful use by recording patient demographics, maintaining an active medication lists and incorporating clinical lab test results into the HER, as apart of their meaningful use objectives. For recording patient demographics, they maintained data for accurate billing and ensured that the practice workflow was adjusted to capture all of the necessary patient data. They addressed active medication lists by following the requirements for e-prescribing. Patients were able to review their active medication list during their visit. Changes to the medication list were reviewed with the nurse and adjusted within the EHR system by the doctor. They communicated information for the care coordination process by making test results efficient and safe to access. Physicians were able to make real time decisions when they receive the test results from LabCorp, Quest, and other health
The government aims to do this by servings as an advocate of Indigenous communities’ interests, promoting Indian communities to achieve their aspirations, and more open communication with greater involvement in planning, budgeting and delivery of health care program. The final pillar addresses the Canadian health systems. This pillar points out the duties of each level of government. The federal governments role is in public health activities on reserve, health promotion, and detection of hazards to health in the environment. The provincial government hold responsibility in treatment of acute and chronic diseases and in rehabilitation.
One important issue that plagues the Canadian health system is the affordability of prescription drugs, which arises from the medication not being covered under Canada’s current universal health care system (Parliament of Canada). The prescription drugs are either paid out of pocket, or covered a certain percentage depending on their private insurance or benefits given by their profession. For those who cannot afford the medication it causes a dilemma, choosing to take on a financial burden for the sake of their own treatment and without taking the needed treatment the disease may get worse. Since it is out-of-the-pocket the wealthy can obtain the medication, while the poor are handcuffed to do so, therefore making this a financial and an equity
A balance between public expectations, medical knowledge, technological change, economic and human resources, and political will. This site is designed to present a narrative history of the people, politics and programs that have contributed to making Medicare a distinctive thread in the web of social progress in Canada (Canada, 2012). The basic values of fairness and equity that are demonstrated by the willingness of Canadians to share resources and responsibility are displayed in Canada’s healthcare system. Also, the system has been and continues to be modified as the country’s population and circumstances change, and as the nature of health care itself evolves. Canada’s publicly funded health care system is dynamic-- reforms have been made over the past four decades and will continue in response to changes within medicine and throughout
-June 9th - Minister of Health announces analytic trials program; individuals who auspiciously administer to Health Canada are absolved from bent case
While leading the innovative digital capabilities project in Canada, my aim was to use innovative technological tools to help achieve our objectives of second-dose adherence and